CAD 0.03
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -413.07 Thousand | -200.23 Thousand | -185.45 Thousand | 58.48 Thousand | -368.14 Thousand | -505.41 Thousand |
Net Income | -559.78 Thousand | -242.33 Thousand | -302.11 Thousand | -8.74 Million | -692.58 Thousand | -2.01 Million |
Depreciation & Amortization | - | - | - | 174.00 | 507.95 Thousand | -63.23 Thousand |
Deferred income taxes | - | - | - | - | -45.83 Thousand | 939.2 Thousand |
Stock-based compensation | 165.41 Thousand | 57.93 Thousand | 213.9 Thousand | - | 8467.00 | 8873.00 |
Change in working capital | -18.7 Thousand | -15.82 Thousand | -83.66 Thousand | 150.07 Thousand | -166.16 Thousand | 349.79 Thousand |
Other non-cash items | 186.96 Thousand | 78.52 Thousand | -13.57 Thousand | 8.65 Million | 20.01 Thousand | 272.87 Thousand |
Investing Cash Flow | - | - | 4200.00 | -188.69 Thousand | -1.14 Million | -2.17 Million |
Investments in PPE | - | - | - | -278.69 Thousand | -1.14 Million | -2.05 Million |
Acquisitions | - | - | 4200.00 | 90 Thousand | - | -261.22 Thousand |
Investment purchases | - | - | - | - | - | -261.22 Thousand |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | 4.20 | 90 Thousand | - | 139.89 Thousand |
Financing Cash Flow | 149 Thousand | - | 620.71 Thousand | 40 Thousand | -6747.00 | 4.36 Million |
Debt repayment | - | - | - | -40 Thousand | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 152.5 Thousand | - | 700 Thousand | - | - | 4.36 Million |
Other Financing Activities | -3500.00 | - | -79.28 Thousand | 40 Thousand | -6747.00 | 4372.32 |
Accounts receivables | -21.54 Thousand | -7952.00 | -21.88 Thousand | -115.58 Thousand | 813.73 Thousand | -531.32 Thousand |
Accounts payables | - | -12.64 Thousand | -57.01 Thousand | 231.13 Thousand | -1.04 Million | 1.08 Million |
Inventory | - | 12.64 Thousand | 57.01 Thousand | -231.13 Thousand | 1.04 Million | 17.35 Thousand |
Other working capital | 2840.00 | -7875.00 | -61.77 Thousand | 265.66 Thousand | -979.89 Thousand | -217.49 Thousand |
Cash at beginning of period | 351.74 Thousand | 551.97 Thousand | 112.52 Thousand | 202.73 Thousand | 1.72 Million | 35.45 Thousand |
Cash at end of period | 87.66 Thousand | 351.74 Thousand | 551.97 Thousand | 112.52 Thousand | 202.73 Thousand | 1.72 Million |
Capital Expenditure | - | - | - | -278.69 Thousand | -1.14 Million | -2.05 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -264.07 Thousand | -200.23 Thousand | 439.45 Thousand | -90.2 Thousand | -1.52 Million | 1.68 Million |
Free Cash Flow | -413.07 Thousand | -200.23 Thousand | -185.45 Thousand | -220.2 Thousand | -1.51 Million | -2.55 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -23.68 Thousand | -45.92 Thousand | -26.33 Thousand | -198.04 Thousand | -559.78 Thousand | -231.75 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | 165.41 Thousand | 162.23 Thousand |
Change in working capital | 12.4 Thousand | -20.23 Thousand | 67.36 Thousand | -28.91 Thousand | -18.7 Thousand | 16.73 Thousand |
Other non-cash items | -10.02 Thousand | -1.00 | -51.88 Thousand | 10.94 Thousand | 186.96 Thousand | 165.98 Thousand |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | 149 Thousand | 149 Thousand |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | 152.5 Thousand | 152.5 Thousand |
Other Financing Activities | - | - | - | - | -3500.00 | -3500.00 |
Accounts receivables | 10.03 Thousand | -96.00 | 51.88 Thousand | -10.94 Thousand | -21.54 Thousand | -3755.00 |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 2370.00 | -20.13 Thousand | 15.48 Thousand | -17.96 Thousand | 2840.00 | 20.48 Thousand |
Cash at beginning of period | 62.54 Thousand | 128.69 Thousand | 87.66 Thousand | 314.62 Thousand | 351.74 Thousand | 218.41 Thousand |
Cash at end of period | 51.26 Thousand | 62.54 Thousand | 128.69 Thousand | 87.66 Thousand | 87.66 Thousand | 314.62 Thousand |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -11.28 Thousand | -66.15 Thousand | 41.02 Thousand | -226.95 Thousand | -264.07 Thousand | 96.2 Thousand |
Free Cash Flow | -11.28 Thousand | -66.15 Thousand | 41.02 Thousand | -226.95 Thousand | -413.07 Thousand | -52.79 Thousand |
308170
CSSPF
SNEGF
BIOFILCHEM
CROISSANCE
MSIU